The MyAide Platform

Dose-level measurement, from dispense to decision

Sensor-verified dose data captured at the point of dispense, processed through clinical models, and delivered as decision-grade evidence to the people who act on it.

MyAide portal dashboard showing adherence analytics

Patient dosing quantity, captured across dosage forms, without disruption

MyAide™ is a measurement platform built to capture precise quantities of medication dispensed, at the moment of dispense, across dosage forms, in the patient’s own hands. The same architecture works whether the container is a pharmacy vial, an ointment tube, a foam dispenser, or a liquid bottle. Smart Dock and Smart Cap are the two form factors in service today. The platform is protected by multiple issued patents across nine countries and has been deployed across thousands of patient days and multiple patient cohorts.

See how it works →

Solid-oral · Vials · Tablets · Capsules

Smart Dock

Configurable for a range of pharmacy vials and medication containers. Measures the amount of medication dispensed at each dose event, and converts that to the number of tablets or capsules removed. Works with oral solids, foams, and gels. NFC detects vial presence with >99% accuracy. Bluetooth and Wi-Fi connected. Patient app optional.

When identity confirmation is enabled, the Dock asks the patient to authenticate at each dose, so the record can carry when, how much, and who. That verified chain of custody matters most where diversion or high-value therapy is a concern.

Validated
100%Dose-quantity agreement (pill count) · κ = 1.00
100%User-identity confirmation · κ = 1.00
99%Time of administration · κ = 0.993
Independent technical validation · University of Houston · Pharmacy, 2025
Read the validation paper →
Smart Dock precision base with pharmacy vial
MyAide
Smart Cap on topical tube
MyAide

Topical · Tubes · Creams · Ointments · Foams

Smart Cap

Fits over standard ointment tubes and foam dispensers, and is designed to extend to liquid bottles. Quantifies medication dispensed by mass plus time and temperature at sub-fingertip-unit precision. The first device to make topical adherence measurable in real-world settings, with the same approach designed to extend to liquids.

Validated
94%Dose-quantity agreement within 0.2g (0.5 FTU) · κ = 0.96
95%Time of dispense within 3 minutes · κ = 0.98
97%Temperature within 3°C · κ = 0.96
Independent technical validation · Wake Forest University School of Medicine
Presented at the JAAD Annual Meeting (2024), with Wake Forest University School of Medicine.
See validation presentation →

Mobile · iOS & Android · Two-way engagement

MyAide app

The patient-facing layer for iOS and Android. Pairs with Smart Dock and Smart Cap to close the loop between device and patient, delivering reminders before a dose is due and alerts when a dose is missed, overdue, or outside the prescribed amount. Patients receive immediate confirmation of each dose and are alerted when a dispense falls outside the prescribed amount, giving them the information to correct and stay on track.

Two-way engagement means patients are not simply monitored but supportively engaged. Every interaction is logged and surfaced to the clinical dashboard automatically.

MyAide App on mobile

iOS & Android · pairs with Smart Dock and Smart Cap

Patient adherence analytics dashboard

Web platform

Adherence analytics dashboard

Clinician- and sponsor-facing. Cohort visualizations, configurable alerts, raw-data export, and the on-target / overdose / underdose timeline view, which plots each dose by the quantity actually measured.

Request a dashboard walkthrough →

From onboarding to intervention

The device sits where the medication sits. The patient changes nothing. The data moves automatically. MyAide™ was designed to minimize effort and hassle for patients, sites, and clinicians.

1

Patient cohorts are enrolled through the admin module

A dedicated login configures each patient’s device and app with their specific regimen (medications, dosing schedule, and instructions) before the device ships.

2

The patient receives their medication and Smart Dock or Smart Cap

The device arrives ready to use with a brief onboarding process, either done by the patient or with minimal supervision. Apps are pre-configured and connected.

3
Ongoing

Each dispensing event is weighed and recorded

The smart devices capture the amount of the dose dispensed in dose-specific units (tablets, fingertip units, teaspoons, drops), and patients receive immediate confirmation.

4
Ongoing

Data transmits to the MyAide platform in real time

Measurements are sent via Bluetooth or Wi-Fi to the cloud, where they are timestamped, validated, and stored in a structured, analysis-ready format.

5
In development

MyAide AI is being built to generate personalized patient engagement

The intelligence layer we are building is designed to interpret each patient’s dispensing pattern and deliver timely, tailored messages reinforcing adherence, flagging interruptions, and adapting over time. Detection of a problem and the choice of response are rule-based and clinician-reviewed. The model personalizes the wording rather than deciding the clinical action.

6
Ongoing

Clinicians and care teams monitor in the dashboard

Authorized users see each patient’s dispensing history, trends, and alerts, without asking the patient to report, estimate, or recall.

7

Sponsors and investigators access structured study data

For clinical trials, the platform exports CDISC-compliant records of actual quantity dispensed per patient, per dose event, traceable and defensible in protocol-deviation review and primary endpoint analyses.

8

The measurement record travels with the study, not the device

At study close or prescription end, the data remains complete, auditable, and ready to support publication, regulatory submission, or outcomes analysis.

← Back to platform overview

The intelligence that decides when, what, and to whom In development

We are building the intelligence layer that turns dose data into clinical action. It is designed to identify patterns, surface emerging concerns, support timely outreach to patients, and give clinicians the context for the moments that matter, on a foundation proxy-based systems cannot offer.

In the design we are developing, the detection of a problem, the classification of the patient, and the selection of a response are rule-based and clinician-reviewed. The model personalizes the wording of a message rather than deciding the clinical action, and a clinician stays in the loop on every recommendation.

Its responses are being built to operate under the MyAide AI Constitution, drawing on three foundations: Anthropic’s constitutional AI methodology, the AMA Code of Medical Ethics, and a trustworthiness framework derived from the foundational consumer trust and accountability research of our founding team.

The system is being developed to use retrieval-augmented generation over a curated clinical knowledge base, with explicit retrieval confidence thresholds and a structured self-evaluation step before each response.

MyAide is being built to read each patient’s measured dosing behavior, combine it with a behavioral profile drawn from brief instruments grounded in our research, and recommend a specific, clinician-reviewed intervention matched to that patient. The behavioral model places each patient on the dimensions that predict response, and pairs that with the dose-level record only quantity measurement can produce. The result is a recommendation that reflects both what the patient did and why they are likely to respond to one approach rather than another.

More scenarios, same blind spot

Three common dosing error scenarios. Each panel shows a seven-day window: what actually happened, what a proxy monitor records, and what MyAide measures at the dose level.

Verified Missed / not recorded
Proxy tech · Pill-bottle cap monitor

Weekly Pillbox Decanting.

Patient decants a week's pills Sunday morning. Bottle not opened again all week.

D1D2D3D4D5D6D7
Prescribed 1111111
Actual 7
Proxy
MyAide ×7

Proxy monitor

One cap-open event. Six days recorded as missed. No action taken.

MyAide

Bulk removal detected. No subsequent doses confirmed. Patient outreach triggered.

Verified Missed
Proxy tech · e-Diary (self-report)

Diary Says Applied. Foam Says Otherwise.

Days 2 and 5 fully missed. Patient logs "applied" in the e-diary both days.

D1D2D3D4D5D6D7
Prescribed 1111111
Actual 1 1 1 1 1
Proxy
MyAide 1 1 1 1 1

Proxy monitor

Full-week compliance recorded. Both missed doses invisible.

MyAide

2 missed doses confirmed. Compliance rate: 71%, not 100%.

Underdose Missed
Proxy tech · Pill cap

Two Prescribed. One Removed.

Two tablets per dose event prescribed. Patient removes only one every day.

D1D2D3D4D5D6D7
Prescribed 2222222
Actual 1111111
Proxy
MyAide 1111111

Proxy monitor

Seven compliant events recorded. Dose quantity not measured.

MyAide

1 tablet under-dispensed, every day. Patient outreach triggered.

Medication intelligence, on a working dataset

Smart Dock, Smart Cap, and MyAide are deployed today, generating dispense-level records across solid oral and topical dosage forms, validated independently at Wake Forest and the University of Houston.